Global Animal Health Market Insights, Forecast to 2025

2 Global Animal Health Quarterly Market Size Analysis

• 2.1 Animal Health Business Impact Assessment - COVID-19
  • 2.1.1 Global Animal Health Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Animal Health Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Animal Health Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Animal Health Headquarters and Area Served
• 3.3 Date of Key Players Enter into Animal Health Market
• 3.4 Key Players Animal Health Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Animal Health Segments, By Type

• 4.1 Introduction
  • 1.4.1 Pharmaceuticals
  • 1.4.2 Feed Additives
  • 1.4.3 Vaccines
• 4.2 By Type, Global Animal Health Market Size, 2019-2021

5 Impact of Covid-19 on Animal Health Segments, By Application

• 5.1 Overview
  • 5.5.1 Companion Animals
  • 5.5.2 Production Animals
• 5.2 By Application, Global Animal Health Market Size, 2019-2021
  • 5.2.1 By Application, Global Animal Health Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Bayer Animal Health
  • 7.1.1 Bayer Animal Health Business Overview
  • 7.1.2 Bayer Animal Health Animal Health Quarterly Revenue, 2020
  • 7.1.3 Bayer Animal Health Animal Health Product Introduction
  • 7.1.4 Bayer Animal Health Response to COVID-19 and Related Developments
• 7.2 Ceva Animal Healthcare
  • 7.2.1 Ceva Animal Healthcare Business Overview
  • 7.2.2 Ceva Animal Healthcare Animal Health Quarterly Revenue, 2020
  • 7.2.3 Ceva Animal Healthcare Animal Health Product Introduction
  • 7.2.4 Ceva Animal Healthcare Response to COVID-19 and Related Developments
• 7.3 Elanco Animal Health
  • 7.3.1 Elanco Animal Health Business Overview
  • 7.3.2 Elanco Animal Health Animal Health Quarterly Revenue, 2020
  • 7.3.3 Elanco Animal Health Animal Health Product Introduction
  • 7.3.4 Elanco Animal Health Response to COVID-19 and Related Developments
• 7.4 Merck Ltd.
  • 7.4.1 Merck Ltd. Business Overview
  • 7.4.2 Merck Ltd. Animal Health Quarterly Revenue, 2020
  • 7.4.3 Merck Ltd. Animal Health Product Introduction
  • 7.4.4 Merck Ltd. Response to COVID-19 and Related Developments
• 7.5 Merial (Animal Health division of Sanofi)
  • 7.5.1 Merial (Animal Health division of Sanofi) Business Overview
  • 7.5.2 Merial (Animal Health division of Sanofi) Animal Health Quarterly Revenue, 2020
  • 7.5.3 Merial (Animal Health division of Sanofi) Animal Health Product Introduction
  • 7.5.4 Merial (Animal Health division of Sanofi) Response to COVID-19 and Related Developments
• 7.6 Zoetis Animal Healthcare
  • 7.6.1 Zoetis Animal Healthcare Business Overview
  • 7.6.2 Zoetis Animal Healthcare Animal Health Quarterly Revenue, 2020
  • 7.6.3 Zoetis Animal Healthcare Animal Health Product Introduction
  • 7.6.4 Zoetis Animal Healthcare Response to COVID-19 and Related Developments
• 7.7 Pfizer
  • 7.7.1 Pfizer Business Overview
  • 7.7.2 Pfizer Animal Health Quarterly Revenue, 2020
  • 7.7.3 Pfizer Animal Health Product Introduction
  • 7.7.4 Pfizer Response to COVID-19 and Related Developments
• 7.8 Vétoquinol SA
  • 7.8.1 Vétoquinol SA Business Overview
  • 7.8.2 Vétoquinol SA Animal Health Quarterly Revenue, 2020
  • 7.8.3 Vétoquinol SA Animal Health Product Introduction
  • 7.8.4 Vétoquinol SA Response to COVID-19 and Related Developments
• 7.9 Sanofi-Aventis
  • 7.9.1 Sanofi-Aventis Business Overview
  • 7.9.2 Sanofi-Aventis Animal Health Quarterly Revenue, 2020
  • 7.9.3 Sanofi-Aventis Animal Health Product Introduction
  • 7.9.4 Sanofi-Aventis Response to COVID-19 and Related Developments
• 7.10 Bayer HealthCare
  • 7.10.1 Bayer HealthCare Business Overview
  • 7.10.2 Bayer HealthCare Animal Health Quarterly Revenue, 2020
  • 7.10.3 Bayer HealthCare Animal Health Product Introduction
  • 7.10.4 Bayer HealthCare Response to COVID-19 and Related Developments
• 7.11 Virbac
  • 7.11.1 Virbac Business Overview
  • 7.11.2 Virbac Animal Health Quarterly Revenue, 2020
  • 7.11.3 Virbac Animal Health Product Introduction
  • 7.11.4 Virbac Response to COVID-19 and Related Developments
• 7.12 Novartis
  • 7.12.1 Novartis Business Overview
  • 7.12.2 Novartis Animal Health Quarterly Revenue, 2020
  • 7.12.3 Novartis Animal Health Product Introduction
  • 7.12.4 Novartis Response to COVID-19 and Related Developments
• 7.13 Boehringer Ingelheim
  • 7.13.1 Boehringer Ingelheim Business Overview
  • 7.13.2 Boehringer Ingelheim Animal Health Quarterly Revenue, 2020
  • 7.13.3 Boehringer Ingelheim Animal Health Product Introduction
  • 7.13.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
• 7.14 Heska Corporation
  • 7.14.1 Heska Corporation Business Overview
  • 7.14.2 Heska Corporation Animal Health Quarterly Revenue, 2020
  • 7.14.3 Heska Corporation Animal Health Product Introduction
  • 7.14.4 Heska Corporation Response to COVID-19 and Related Developments
• 7.15 Bioniche Animal Health Canada, Inc.
  • 7.15.1 Bioniche Animal Health Canada, Inc. Business Overview
  • 7.15.2 Bioniche Animal Health Canada, Inc. Animal Health Quarterly Revenue, 2020
  • 7.15.3 Bioniche Animal Health Canada, Inc. Animal Health Product Introduction
  • 7.15.4 Bioniche Animal Health Canada, Inc. Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US